With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line
Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?
The secret reasons why statins may not be as useful as we think
Statins for everyone over 40? What patients need to think about before filling that prescription
High stakes in ballot battle over rising prescription drug costs
Black box warnings for ‘lifesaving’ hepatitis C drugs highlight systematic misinformation
What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups
Seven intriguing angles on the EpiPen price-gouging story
Where are the TV ads to “educate” patients about the negative Opdivo lung cancer trial?
What journalists and consumers should know about the tug-of-war between biologics and generic ‘biosimilars’